S. Aureus Translocation From Skin and Nose to Periprosthetic Tissues
Condition: Staphylococcus Aureus Intervention: Sponsor: Rothman Institute Orthopaedics Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2020 Category: Research Source Type: clinical trials
First-in-human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors
Conditions: Solid Tumor, Adult; FGFR2 Amplification; FGFR2 Gene Mutation; FGFR2 Gene Rearrangement; FGFR2 Gene Translocation; FGFR2 Gene Activation; Intrahepatic Cholangiocarcinoma; Cholangiocarcinoma; Endometrial Cancer; Gastric Cancer; Breast Cancer Intervention: Drug: RLY-4008 Sponsor: Relay Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2020 Category: Research Source Type: clinical trials